Rheumatoid Arthritis Clinical Trials in Chicago

Showing 3681-3700 of 3,890 trials

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

NCT00510419

The purpose of this research study is to evaluate an investigational auto-injector system for delivering sumatriptan under the skin for a single migraine attack. The study could take approximately 5 weeks and will include about 3 office visits to the study doctor, the patient will be contacted every 2 weeks until the patient experiences a migraine and uses the auto-injector. The last visit will be done by a telephone follow-up call.

Migraine

Pfizer73 participantsStarted Jul 2007

San Francisco, California, United States • Stamford, Connecticut, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPhase 22.2 miles

Study of CP-675,206 in Refractory Melanoma

NCT00254579

CP-675,206 is a fully human monoclonal antibody (mAb). It binds to the CTLA4 molecule, which is expressed on the surface of activated T lymphocytes. CP-675,206 is thought to stimulate patients' immune systems to attack their tumors. CP-675,206 is not expected to have a direct effect on tumor cells. CP-675,206 been shown to induce durable tumor responses in patients with metastatic melanoma in Phase 1 and Phase 2 clinical studies.

Refractory Melanoma

AstraZeneca251 participantsStarted Dec 2005

Scottsdale, Arizona, United States • Bentonville, Arkansas, United States • Fayetteville, Arkansas, United States +62 more locations

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Study of CP-675,206 in Refractory Melanoma

Rheumatoid Arthritis Trials in Other Cities

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty

Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

Expanding and Testing VA Collaborative Care Models for Depression

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

Dose Finding Posterolateral Thoracotomy Study

Other Conditions in Chicago